Work

Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway

Year: 2018

Type: article

Source: Cancer Letters

DOI: 10.1016/j.canlet.2018.12.010

Authors: Jichuang Wang, Nan Zhang, Qi Han, Wenxian Lu, Long Wang, Dayun Yang, Min Zheng, Zhenzhen Zhang, Hekun Liu, Tae Ho Lee, Xiao Zhen Zhou, Kun Ping Lu

Institutions: Fujian Medical University, Broad Institute, Beth Israel Deaconess Medical Center, Harvard University

Language: English

Topic: Signaling Pathways in Disease

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Natural Science Foundation of Fujian Province, Fujian Medical University, National Institutes of Health, National Cancer Institute

Awards: G143822220, Function and Regulation of the Phosphorylation-Specific Prolyl Isomerase Pin1, G2457810548, Development of selective Pin1 inhibitors to target a common oncogenic mechanism

OpenAlex ID: W2906151064

FWCI: 2.668

Cites: 44

Cited by: 87

Related to: 10